Literature DB >> 23032388

Presupplementary motor area hyperactivity during response inhibition: a candidate endophenotype of obsessive-compulsive disorder.

Stella J de Wit1, Froukje E de Vries, Ysbrand D van der Werf, Danielle C Cath, Dirk J Heslenfeld, Eveline M Veltman, Anton J L M van Balkom, Dick J Veltman, Odile A van den Heuvel.   

Abstract

OBJECTIVE: Endophenotype studies of obsessive-compulsive disorder (OCD) may uncover heritable traits that are related to genetic susceptibility to OCD. Deficient response inhibition is a promising endophenotype of OCD, although its functional neural correlates have not been extensively studied. The authors sought to determine the functional neural correlates of response inhibition in a large sample of medication-free OCD patients and their unaffected siblings.
METHOD: Forty-one OCD patients, 17 of their siblings, and 37 matched healthy comparison subjects performed a stop-signal task during 3-T functional MRI. The stop-signal reaction time provided a behavioral measure of response inhibition. The neural correlates of response inhibition were assessed in a region-of-interest analysis that included the presupplementary motor area, inferior frontal gyrus, subthalamic nucleus, and inferior parietal cortex.
RESULTS: Patients with OCD had greater stop-signal reaction times relative to healthy comparison subjects. The numerical stop-signal reaction time difference between siblings and comparison subjects failed to reach significance. Both patients with OCD and their siblings showed greater activity in the left presupplementary motor area during successful inhibition relative to comparison subjects. Relative to both the comparison subjects and the siblings, patients with OCD showed decreased activity in the right inferior parietal cortex and inferior frontal gyrus. In patients and siblings, presupplementary motor area activity correlated negatively with stop-signal reaction time.
CONCLUSIONS: These findings suggest that presupplementary motor area hyperactivity is a neurocognitive endophenotype of OCD that is possibly related to inefficient neural processing within the presupplementary motor area itself. Patients with OCD further showed a state-dependent deficit in recruiting right inferior parietal cortex and inferior frontal gyrus, which may contribute to their inhibition deficit.

Entities:  

Mesh:

Year:  2012        PMID: 23032388     DOI: 10.1176/appi.ajp.2012.12010073

Source DB:  PubMed          Journal:  Am J Psychiatry        ISSN: 0002-953X            Impact factor:   18.112


  85 in total

1.  Development of Posterior Medial Frontal Cortex Function in Pediatric Obsessive-Compulsive Disorder.

Authors:  Kate Dimond Fitzgerald; Yanni Liu; Timothy D Johnson; Jason S Moser; Rachel Marsh; Gregory L Hanna; Stephan F Taylor
Journal:  J Am Acad Child Adolesc Psychiatry       Date:  2018-04-21       Impact factor: 8.829

2.  OCD is associated with an altered association between sensorimotor gating and cortical and subcortical 5-HT1b receptor binding.

Authors:  Christopher Pittenger; Thomas G Adams; Jean-Dominique Gallezot; Michael J Crowley; Nabeel Nabulsi; Hong Gao; Stephen A Kichuk; Ryan Simpson; Eileen Billingslea; Jonas Hannestad; Michael Bloch; Linda Mayes; Zubin Bhagwagar; Richard E Carson
Journal:  J Affect Disord       Date:  2016-02-09       Impact factor: 4.839

Review 3.  Transcranial direct current stimulation in psychiatric disorders.

Authors:  Gabriel Tortella; Roberta Casati; Luana V M Aparicio; Antonio Mantovani; Natasha Senço; Giordano D'Urso; Jerome Brunelin; Fabiana Guarienti; Priscila Mara Lorencini Selingardi; Débora Muszkat; Bernardo de Sampaio Pereira Junior; Leandro Valiengo; Adriano H Moffa; Marcel Simis; Lucas Borrione; André R Brunoni
Journal:  World J Psychiatry       Date:  2015-03-22

Review 4.  Obsessive-compulsive disorder: an integrative genetic and neurobiological perspective.

Authors:  David L Pauls; Amitai Abramovitch; Scott L Rauch; Daniel A Geller
Journal:  Nat Rev Neurosci       Date:  2014-06       Impact factor: 34.870

Review 5.  Cognitive inflexibility in Obsessive-Compulsive Disorder.

Authors:  Patricia Gruner; Christopher Pittenger
Journal:  Neuroscience       Date:  2016-08-01       Impact factor: 3.590

Review 6.  Biological markers for anxiety disorders, OCD and PTSD: A consensus statement. Part II: Neurochemistry, neurophysiology and neurocognition.

Authors:  Borwin Bandelow; David Baldwin; Marianna Abelli; Blanca Bolea-Alamanac; Michel Bourin; Samuel R Chamberlain; Eduardo Cinosi; Simon Davies; Katharina Domschke; Naomi Fineberg; Edna Grünblatt; Marek Jarema; Yong-Ku Kim; Eduard Maron; Vasileios Masdrakis; Olya Mikova; David Nutt; Stefano Pallanti; Stefano Pini; Andreas Ströhle; Florence Thibaut; Matilde M Vaghi; Eunsoo Won; Dirk Wedekind; Adam Wichniak; Jade Woolley; Peter Zwanzger; Peter Riederer
Journal:  World J Biol Psychiatry       Date:  2016-07-15       Impact factor: 4.132

Review 7.  A Meta-Analysis of the Effectiveness of Different Cortical Targets Used in Repetitive Transcranial Magnetic Stimulation (rTMS) for the Treatment of Obsessive-Compulsive Disorder (OCD).

Authors:  Simone Rehn; Guy D Eslick; Vlasios Brakoulias
Journal:  Psychiatr Q       Date:  2018-09

Review 8.  Role of functional imaging in the development and refinement of invasive neuromodulation for psychiatric disorders.

Authors:  Nolan R Williams; Joseph J Taylor; Kayla Lamb; Colleen A Hanlon; E Baron Short; Mark S George
Journal:  World J Radiol       Date:  2014-10-28

9.  Neurochemicals measured by (1)H-MR spectroscopy: putative vulnerability biomarkers for obsessive compulsive disorder.

Authors:  Sundar Gnanavel; Pratap Sharan; Sudhir Khandelwal; Uma Sharma; Naranamangalam R Jagannathan
Journal:  MAGMA       Date:  2013-12-12       Impact factor: 2.310

10.  The Role of Response Inhibition in Medicated and Unmedicated Obsessive-Compulsive Disorder Patients: Evidence from the Stop-Signal Task.

Authors:  Eyal Kalanthroff; Tobias Teichert; Michael G Wheaton; Marcia B Kimeldorf; Omer Linkovski; Susanne E Ahmari; Abby J Fyer; Franklin R Schneier; Gideon E Anholt; H Blair Simpson
Journal:  Depress Anxiety       Date:  2016-03-17       Impact factor: 6.505

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.